Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Bellodi

Showing results (51-60 of 150) with videos related to

Pageof 15
Sort By:
The American Journal of Psychiatry|April 1, 1995
Sensitivity to 35% CO2 in healthy first-degree relatives of patients with panic disorderG Perna, S Cocchi, A Bertani, et al.
Brain and Cognition|August 7, 2001
A neuropsychological study of dissociation in cortical and subcortical functioning in obsessive-compulsive disorder by Tower of Hanoi taskP Cavedini, M Cisima, G Riboldi, et al.
Psychoneuroendocrinology|October 1, 1979
Dopamine receptor sensitivity in the hypothalamus of chronic schizophrenics after haloperidol therapy: growth hormone and prolactin response to stimuliF Brambilla, L Bellodi, F Negri, et al.
Journal of Clinical Psychopharmacology|December 1, 1994
Pharmacologic effect of toloxatone on reactivity to the 35% carbon dioxide challenge: a single-blind, random, placebo-controlled studyG Perna, S Cocchi, A Bertani, et al.
Biological Psychiatry|October 6, 1997
Asthma and panic attacksG Perna, A Bertani, E Politi, et al.
Journal of Clinical Psychopharmacology|June 1, 1997
Modification of 35% carbon dioxide hypersensitivity across one week of treatment with clomipramine and fluvoxamine: a double-blind, randomized, placebo-controlled studyG Perna, A Bertani, A Gabriele, et al.
Biological Psychiatry|November 14, 1997
Dopamine function in obsessive-compulsive disorder: growth hormone response to apomorphine stimulationF Brambilla, L Bellodi, G Perna, et al.
Archives of General Psychiatry|February 15, 2001
Modulation by muscarinic antagonists of the response to carbon dioxide challenge in panic disorderM Battaglia, S Bertella, A Ogliari, et al.
Journal of Clinical Psychopharmacology|June 2, 2001
The 35% CO2 hyperreactivity and clinical symptomatology in patients with panic disorder after 1 week of treatment with citalopram: an open studyA Bertani, D Caldirola, R Bussi, et al.
Comprehensive Psychiatry|November 1, 1995
Comorbidity of panic and somatization disorder: a genetic-epidemiological approachM Battaglia, L Bernardeschi, E Politi, et al.
Pageof 15

Showing results (51-60 of 150) with videos related to

Sort By:
Pageof 15
The American Journal of Psychiatry|April 1, 1995
Sensitivity to 35% CO2 in healthy first-degree relatives of patients with panic disorderG Perna, S Cocchi, A Bertani, et al.
Brain and Cognition|August 7, 2001
A neuropsychological study of dissociation in cortical and subcortical functioning in obsessive-compulsive disorder by Tower of Hanoi taskP Cavedini, M Cisima, G Riboldi, et al.
Psychoneuroendocrinology|October 1, 1979
Dopamine receptor sensitivity in the hypothalamus of chronic schizophrenics after haloperidol therapy: growth hormone and prolactin response to stimuliF Brambilla, L Bellodi, F Negri, et al.
Journal of Clinical Psychopharmacology|December 1, 1994
Pharmacologic effect of toloxatone on reactivity to the 35% carbon dioxide challenge: a single-blind, random, placebo-controlled studyG Perna, S Cocchi, A Bertani, et al.
Biological Psychiatry|October 6, 1997
Asthma and panic attacksG Perna, A Bertani, E Politi, et al.
Journal of Clinical Psychopharmacology|June 1, 1997
Modification of 35% carbon dioxide hypersensitivity across one week of treatment with clomipramine and fluvoxamine: a double-blind, randomized, placebo-controlled studyG Perna, A Bertani, A Gabriele, et al.
Biological Psychiatry|November 14, 1997
Dopamine function in obsessive-compulsive disorder: growth hormone response to apomorphine stimulationF Brambilla, L Bellodi, G Perna, et al.
Archives of General Psychiatry|February 15, 2001
Modulation by muscarinic antagonists of the response to carbon dioxide challenge in panic disorderM Battaglia, S Bertella, A Ogliari, et al.
Journal of Clinical Psychopharmacology|June 2, 2001
The 35% CO2 hyperreactivity and clinical symptomatology in patients with panic disorder after 1 week of treatment with citalopram: an open studyA Bertani, D Caldirola, R Bussi, et al.
Comprehensive Psychiatry|November 1, 1995
Comorbidity of panic and somatization disorder: a genetic-epidemiological approachM Battaglia, L Bernardeschi, E Politi, et al.
Pageof 15